Amgen Inc: (NSDQ: AMGN)

(U.S: NSDQ) As of Dec 24, 2014 03:58 PM ET

 Add to portfolio

$160.67 USD

+3.15 (2.04%)

Volume: 2,222,853

Zacks Rank : 1-Strong Buy [?] 1        

Brokerage Reports

Search for reports:

0 items in cart

AMGEN INC [AMGN]

Reports for Purchase

Showing records 1 - 20 ( 195 total )

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 1

12/05/2014

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 2

11/19/2014

Industry Report

Pages: 5

October Script Data Offers an Early Look at Q414This report contains brief updates on the following: AMAG, AMGN, CELG. These companies are covered in more detail in separate Daily Notes and/or Company Reports.

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 10.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 3

11/17/2014

Industry Report

Pages: 4

Biotechnology -AHA Positive on the Margins for PCSK9 Inhibitors

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 10.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 4

11/07/2014

Industry Report

Pages: 7

Biotechnology - ASH 2014 Shaping Up as Mostly Incremental for Our List

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 5

10/28/2014

Company Report

Pages: 5

Impressive Leverage Continues; Still Seeking Meaningful Top Line Growth

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 10.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 6

10/27/2014

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 7

10/22/2014

Industry Report

Pages: 5

Biotechnology: September Script Data Offers a Last Look at Q314 Ahead of Reporting

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 10.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 8

10/13/2014

Industry Report

Pages: 9

Biotechnology - All Things Considered, Anticipate a Solid Q314

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 9

09/24/2014

Industry Report

Pages: 7

August Script Data Gives a Better Look at Q314 Commercial Progress

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 10

09/08/2014

Company Report

Pages: 14

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 11

08/20/2014

Industry Report

Pages: 7

Biotechnology: July Script Data Offers First Look at Q314 Progress

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 12

07/31/2014

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 13

07/30/2014

Company Report

Pages: 8

Inventory Helps Q214 Beat, but Restructuring Likely Grabs More Attention

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 14

07/23/2014

Industry Report

Pages: 7

June Institutional Script Data Posts; Just Ahead of Q214 Reporting

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 15

07/17/2014

Industry Report

Pages: 15

Biotechnology -Looking for a Q214 Rebound

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 50.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 16

06/25/2014

Industry Report

Pages: 6

Biotechnology -May Institutional Data Gives a Look into Q214

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 17

05/21/2014

Industry Report

Pages: 7

Biotechnology - First Look at Q214 with April Script Data

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 18

05/06/2014

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 19

04/23/2014

Company Report

Pages: 8

A Q1 Miss Usually No Big Deal, but This One More Bothersome

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 20

04/23/2014

Industry Report

Pages: 6

Just in Time - March Script Data Offers One More Glimpse At Q114

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00